Midday Market Update: Key Stock Movements
- Rogers shares surged 10% following positive earnings guidance.
- Liquidia shares dropped 25% after a patent infringement ruling, while United Therapeutics rose 15%.
- Jabil’s stock fell 7% despite beating earnings expectations.
Several companies made significant moves in midday trading with varying impacts on their stock values. Rogers, a circuit materials manufacturer, experienced a 10% surge in share prices following its announcement of improved earnings guidance, projecting full-year earnings of around $3.80 per share, surpassing the FactSet consensus estimate of $3.65 per share.
In a contrasting development, Liquidia’s stock plummeted approximately 25% after the U.S. District Court in Delaware ruled that the company infringed on a patent held by United Therapeutics. The court also dismissed Liquidia’s motion regarding United’s challenge related to another patent’s prior art status. Meanwhile, United Therapeutics shares climbed 15% in response to the ruling.
Jabil, the electronics manufacturer, fell over 7% despite reporting fiscal fourth-quarter results that exceeded analysts’ expectations. The company posted earnings of $4.40 per share on an adjusted basis and a revenue of $10.62 billion, while analysts had forecasted a profit of $4.07 per share and revenue of $9.71 billion. Both first-quarter and full-year earnings guidance also surpassed estimates.
Concentrix saw its stock rise 5% after reporting adjusted earnings in its fiscal third quarter above expectations. However, guidance for non-GAAP earnings per share and revenue for the upcoming quarter was below analysts’ projections. The company indicated during its earnings call that its transition towards AI is exerting pressure on revenues.
Moderna shares declined 7% after Citi downgraded the stock to “sell,” with analysts at the bank establishing a price target 60% lower than the stock’s closing price from Tuesday, indicating that the current valuation is unjustifiable.
FormFactor’s stock rose 8% after Deutsche Bank initiated coverage with a buy rating. Analysts noted that FormFactor is well-positioned to benefit from increased chip testing intensity and highlighted its role as “the second source of probe cards for Nvidia’s GPUs at TSMC.”
Lastly, Cal-Maine Foods reported a wider-than-expected loss in its fiscal first-quarter earnings, resulting in a 2% decline in its stock price. The company reported a loss of $1.26 per share, compared to the anticipated loss of 77 cents per share per analysts surveyed by FactSet.
News Courtesy of CNBC
